search
Back to results

Enhancing Diabetes Management Approaches for Black and Hispanic Patients With Uncontrolled Diabetes

Primary Purpose

Diabetes, Diabetes Type 2

Status
Not yet recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
MTM
CHW
Sponsored by
University of Wisconsin, Madison
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Diabetes

Eligibility Criteria

18 Years - 90 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Men and women ages 18-90 with diagnosed type 2 diabetes who self-identify as Black or Hispanic and can speak or read English or Spanish. Taking at least one oral or injectable diabetes medication and have their diabetes medicine prescriptions filled by study pharmacy. Most recent HbA1c ≥ 8% based on point of care test. Will reside in the geographical area throughout the study period. Have access to a phone during the study period. Willing to attend all orientation/training sessions. Exclusion Criteria: Having a caregiver who is the main decision maker in self-management. Participating in another lifestyle, or medication adherence program. Participated in standard MTM/MTM-related intervention in the last 6 months.

Sites / Locations

  • University of Wisconsin

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

No Intervention

Experimental

Experimental

Experimental

Arm Label

Usual Care

Medication Therapy Management (MTM)

Community Health Worker (CHW)

MTM + CHW

Arm Description

Outcomes

Primary Outcome Measures

Change in mean hemoglobin A1c score
HbA1c will be measured, and the mean change will be compared across arms
Change in mean hemoglobin A1c score
HbA1c will be measured, and the mean change will be compared across arms
Change in medication adherence - medication refill
Pharmacy medication refill measured by Proportion of Days Covered and Medication Possession Ratio in subjects receiving MTM, CHW support, or both, compared to those receiving usual care.
Change in medication adherence
Mean scores on the Adherence to Refills and Medications Scale for Diabetes in subjects receiving MTM, CHW support, or both, compared to those receiving usual care.

Secondary Outcome Measures

Full Information

First Posted
June 12, 2023
Last Updated
August 3, 2023
Sponsor
University of Wisconsin, Madison
search

1. Study Identification

Unique Protocol Identification Number
NCT05912647
Brief Title
Enhancing Diabetes Management Approaches for Black and Hispanic Patients With Uncontrolled Diabetes
Official Title
A Multiphase Optimization Strategy to Enhance Diabetes Management Interventions for Black and Hispanic Patients With Uncontrolled Diabetes
Study Type
Interventional

2. Study Status

Record Verification Date
August 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
March 2024 (Anticipated)
Primary Completion Date
December 2027 (Anticipated)
Study Completion Date
December 2027 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Wisconsin, Madison

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of the study is to learn about the best way to enhance pharmacy-related care for diabetes self-management. This research is being done because we want to improve use of medicines and diabetes management among Black and Hispanic adults with type 2 diabetes and find out which of type of support may improve diabetes self-management for Black and Hispanic adults. Participants will be assigned to one of 4 groups, and will either: receive care as usual; or, receive added medicine management support from a pharmacist; or, receive support from a Community Health Worker (CHW) to address life challenges; or, receive both the pharmacist medicine management and the CHW support
Detailed Description
For the Pharmacist plus Support intervention, all participants will receive usual care for their diabetes management. Participants will be randomized to one of four treatment conditions: 1. Usual Care, 2. Medication Therapy Management (MTM) Optimizing Medication Therapy (ON), 3. Community Health Worker (CHW) addressing social determinants of health (SDOH) and diabetes and medicine misperceptions (ON), or 4. both MTM Optimizing Medication Therapy and CHW Addressing SDOH and diabetes and medicine misperceptions for 6 months. Subjects randomized to the treatment conditions including MTM will receive a minimum of five pharmacist-delivered Medication Therapy Management (MTM) sessions with a pharmacist, two in the first month, one medication review each in the second and third month, and a final medication review at 6 months. Subjects randomized to the treatment conditions including CHW support addressing social determinants of health (SDOH) which will involve meeting with the CHW for a formal, standardized 2-hour assessment of five common SDOH barriers related to diabetes management, (1) food insecurity, (2) transportation, (3) prescription medication assistance, (4) access to diabetes education, and (5) physical activity resources (See Table 6). After the initial session at the participant's home, the participant will have the option of continuing to work with the CHW to address barriers for the intervention duration. CHW support will also address diabetes and medicine misperceptions by completing a series of phone calls with the subject to provide information about managing diabetes and medicines, discuss cultural health misperceptions, share medication adherence experiences, and provide social support over the phone.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diabetes, Diabetes Type 2

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
376 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Usual Care
Arm Type
No Intervention
Arm Title
Medication Therapy Management (MTM)
Arm Type
Experimental
Arm Title
Community Health Worker (CHW)
Arm Type
Experimental
Arm Title
MTM + CHW
Arm Type
Experimental
Intervention Type
Behavioral
Intervention Name(s)
MTM
Intervention Description
Participants will receive added medicine management support from a pharmacist. This will involve one 60-minute session with the pharmacist either in-person or over the phone and at least four 30-minute follow-up sessions with the pharmacist over the phone.
Intervention Type
Behavioral
Intervention Name(s)
CHW
Intervention Description
Participants will receive support from a Community Health Worker (CHW) to address life challenges that might be affecting their health and diabetes and to discuss diabetes beliefs and concerns. This will involve one ~30-minute phone call with the CHW to discuss needs and a 2-hour session with the CHW in-person for a comprehensive assessment. Participants will also receive ~10, 15 to 30-minute calls from the CHW to discuss diabetes beliefs and concerns.
Primary Outcome Measure Information:
Title
Change in mean hemoglobin A1c score
Description
HbA1c will be measured, and the mean change will be compared across arms
Time Frame
Baseline to 6 months
Title
Change in mean hemoglobin A1c score
Description
HbA1c will be measured, and the mean change will be compared across arms
Time Frame
Baseline to 12 months
Title
Change in medication adherence - medication refill
Description
Pharmacy medication refill measured by Proportion of Days Covered and Medication Possession Ratio in subjects receiving MTM, CHW support, or both, compared to those receiving usual care.
Time Frame
Baseline to 12 months
Title
Change in medication adherence
Description
Mean scores on the Adherence to Refills and Medications Scale for Diabetes in subjects receiving MTM, CHW support, or both, compared to those receiving usual care.
Time Frame
Baseline to 12 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Men and women ages 18-90 with diagnosed type 2 diabetes who self-identify as Black or Hispanic and can speak or read English or Spanish. Taking at least one oral or injectable diabetes medication and have their diabetes medicine prescriptions filled by study pharmacy. Most recent HbA1c ≥ 8% based on point of care test. Will reside in the geographical area throughout the study period. Have access to a phone during the study period. Willing to attend all orientation/training sessions. Exclusion Criteria: Having a caregiver who is the main decision maker in self-management. Participating in another lifestyle, or medication adherence program. Participated in standard MTM/MTM-related intervention in the last 6 months.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Martha Maurer
Phone
608-265-2662
Email
mamaurer@wisc.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Olayinka Shiyanbola, PhD, BPharm
Organizational Affiliation
University of Wisconsin, Madison
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Wisconsin
City
Madison
State/Province
Wisconsin
ZIP/Postal Code
53705
Country
United States
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Martha Maurer
Phone
608-265-2662
Email
mamaurer@wisc.edu

12. IPD Sharing Statement

Learn more about this trial

Enhancing Diabetes Management Approaches for Black and Hispanic Patients With Uncontrolled Diabetes

We'll reach out to this number within 24 hrs